DNA Electronics has been named as the winner of the R+D prize at the Elektra09 European Electronics Industry Awards for its SNP Dr silicon chip-based handheld device.
The device offers fast and accurate spot-test results for specific DNA sequences that indicate how patients are likely to respond to prescription drugs.
The device is being trialled in partnership with Pfizer.
A test to identify people likely to react badly to prescribed medication will enable doctors to tailor dosages to the individual needs of patients.
The core technology is based upon switching transistors on and off with DNA, which has culminated in the world's first DNA logic on standard CMOS technology.
